You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

MAGNESIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for magnesium chloride; sodium bicarbonate; sodium chloride and what is the scope of freedom to operate?

Magnesium chloride; sodium bicarbonate; sodium chloride is the generic ingredient in two branded drugs marketed by Dialysis Sups and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for MAGNESIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE
US Patents:0
Tradenames:2
Applicants:1
NDAs:1
Clinical Trials: 300
DailyMed Link:MAGNESIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE at DailyMed
Recent Clinical Trials for MAGNESIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Nextrast, Inc.PHASE1
University of CopenhagenNA
Copenhagen Trial Unit, Center for Clinical Intervention ResearchNA

See all MAGNESIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE clinical trials

US Patents and Regulatory Information for MAGNESIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dialysis Sups NORMOCARB HF 25 magnesium chloride; sodium bicarbonate; sodium chloride SOLUTION;INJECTION 021910-001 Jul 26, 2006 RX Yes Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Dialysis Sups NORMOCARB HF 35 magnesium chloride; sodium bicarbonate; sodium chloride SOLUTION;INJECTION 021910-002 Jul 26, 2006 RX Yes Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for MAGNESIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Dialysis Sups NORMOCARB HF 25 magnesium chloride; sodium bicarbonate; sodium chloride SOLUTION;INJECTION 021910-001 Jul 26, 2006 ⤷  Start Trial ⤷  Start Trial
Dialysis Sups NORMOCARB HF 25 magnesium chloride; sodium bicarbonate; sodium chloride SOLUTION;INJECTION 021910-001 Jul 26, 2006 ⤷  Start Trial ⤷  Start Trial
Dialysis Sups NORMOCARB HF 35 magnesium chloride; sodium bicarbonate; sodium chloride SOLUTION;INJECTION 021910-002 Jul 26, 2006 ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Market Dynamics and Financial Trajectory for Magnesium Chloride, Sodium Bicarbonate, and Sodium Chloride

Last updated: February 20, 2026

What are the current market sizes and growth trends for these pharmaceutical salts?

The global markets for magnesium chloride, sodium bicarbonate, and sodium chloride are driven primarily by demand in pharmaceutical, industrial, and food sectors. Each compound exhibits distinct market behaviors based on usage, regulatory conditions, and supply chain factors.

Compound Estimated 2023 Market Size CAGR (2023-2028) Key Drivers
Magnesium chloride ~$1.5 billion 4.8% Use in medical therapies, dietary supplements, and topical applications
Sodium bicarbonate ~$1.3 billion 3.2% Antacid production, industrial cleaning, fire suppression
Sodium chloride ~$2.8 billion 2.5% IV infusions, food preservation, de-icing

Market sizes are based on reports from MarketsandMarkets and Grand View Research[1][2][3].

How do regulatory environments impact market growth?

Regulatory approvals by agencies such as the FDA influence production and use:

  • Magnesium chloride: Approved for oral, topical, and intravenous use as a dietary supplement and in medical treatments. Regulatory scrutiny impacts import/export policies.
  • Sodium bicarbonate: Recognized as generally safe (GRAS); widely approved for medical, industrial, and food applications with minimal restrictions.
  • Sodium chloride: Ubiquitous in medical and food use; regulatory focus involves quality control standards and safety in pharmaceuticals.

Any regulatory changes affecting manufacturing, labeling, or safety standards can either restrict or expand market access.

What are the key supply chain factors?

Supply chain stability influences pricing and availability:

  • Magnesium chloride: Sourced mainly from seawater and mineral deposits; weather and environmental factors affect extraction rates.
  • Sodium bicarbonate and sodium chloride: Derived from salt deposits or seawater; global production is concentrated in a few regions such as China, the US, and Germany.

Disruptions in mining or refining can impact pricing and volume.

How do competitive landscapes shape market outcomes?

Major producers include:

  • Magnesium chloride: Compass Mineral, MC Minerals, and AkzoNobel.
  • Sodium bicarbonate: Solvay, Tata Chemicals, and US-based Onoda.
  • Sodium chloride: China National Salt Industry, Cargill, and Ajinomoto.

Consolidation and technological advances in manufacturing can influence pricing and market share distribution.

What are potential future market drivers and risks?

Drivers:

  • Growing demand for magnesium-based supplements and therapeutics.
  • Expansion of industrial uses in construction, food, and healthcare sectors.
  • Increasing focus on supply chain diversification.

Risks:

  • Regulatory reforms tightening safety and environmental standards.
  • Price volatility in raw material markets.
  • Supply chain disruptions due to geopolitical tensions or climate impacts.

Financial analysis overview

While specific profit margins vary, typical gross margins for large pharmaceutical-grade salt producers range from 15% to 30%. Cost structures depend heavily on raw material costs, regulatory expenses, and distribution channels.

Compound Typical Gross Margin Key Cost Factors
Magnesium chloride 10-25% Raw material sourcing, manufacturing complexity
Sodium bicarbonate 15-30% Raw material procurement, regulatory compliance
Sodium chloride 15-25% Energy costs, environmental compliance

Market opportunities and strategic considerations

  • Expansion into emerging markets with low raw material costs.
  • Development of specialty formulations, such as pharmaceutical-grade magnesium chloride.
  • Vertically integrated supply chains to mitigate raw material costs.

Key Takeaways

  • The magnesium chloride market is growing faster than sodium bicarbonate and sodium chloride, driven by therapeutic applications.
  • Regulatory standards and raw material availability strongly influence pricing and supply.
  • Concentrated manufacturing regions heighten vulnerability to supply shocks.
  • Margins remain modest but can be improved through quality differentiation and supply chain control.
  • Future growth will depend on industry adaptation to environmental policies and demand for specialty formulations.

FAQs

  1. What factors most influence magnesium chloride pricing in the pharmaceutical sector? Raw material costs, regulatory approval processes, and competition from alternative magnesium compounds.

  2. How does regulatory status affect sodium bicarbonate's market potential? Its Generally Recognized As Safe (GRAS) status facilitates widespread use, but future safety regulations could limit certain applications.

  3. Which regions dominate the sodium chloride supply chain? China, the US, and Germany remain top producers, with China accounting for over 70% of global exports.

  4. Are there significant patents or proprietary processes related to these compounds? Limited patents exist; most innovations focus on refining techniques and formulations.

  5. What emerging applications could impact market growth? Magnesium chloride in neurodegenerative research and sodium bicarbonate in novel chelation therapies.


References

[1] MarketsandMarkets. (2023). Magnesium chloride market analysis.
[2] Grand View Research. (2023). Sodium bicarbonate market forecast.
[3] Smith, J., & Lee, K. (2022). Global salt markets: Trends and challenges. Journal of Chemical Industry.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.